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Abstract
L-asparaginase (L-asparagine amino
hydrolase) is an enzyme which was clinically
proved as an antitumor agent to treat acute
lymphoblastic leukemia. It catalyzes L-asparagine
hydrolysis to L-aspartate and ammonia, and the
depletion of asparagine causes cytotoxicity to
leukemic cells. Microbial L-asparaginase
(ASNase) production has attracted good attention
regarding its cost effectiveness and eco-
friendliness. The focus of this review is to provide
a discussion regarding the microbial ASNase
production, purification, its mechanism of action,
sources, therapeutic side effects and focusing on
the future prospects like protein engineering,
recombinant microorganisms to develop a efficient
therapeutics with significantly less side effects.
This study is also focusing on the production of
ASNases from new sources with improvement in
the availability as a drug, and  issues related to
reducing the cost of the drug by improving the
pharmacokinetics, pharmaco-dynamics and
toxicological profiles in producing the  ASNase
enzyme.
Key words: Microbial L-asparaginase production,
Biopharmaceutical drug, Acute Lymphoblastic
leukemia.
Introduction
L-asparaginase (ASNase) is an enzymatic
drug used in chemotherapy against diseases such
as acute lymphoblastic leukemia (ALL),
lymphosarcoma, Hodgkin’s disease (1). Tumor
cells, more specifically lymphatic tumor cells,
requires high amount of asparagine to survive with
their rapid malignant growth. This drug depletes
L-asparagine (Asn) in to L-aspartate and ammonia
in blood, blocking protein synthesis in T-cells and
inhibiting DNA and RNA synthesis in cancer cells.
As a result, cell functions are impaired resulting
in apoptosis. However, normal cells are capable
to synthesize their own Asn and are less affected
by its depletion by treatment with ASNase.
Nonetheless, when the drug was used for long-
term treatment, it may cause hypersensitivity
leading to allergic reactions such as respiratory
disorders, skin rashes, low blood pressure, loss
of consciousness (2). Various ASNase
preparations from Escherichia coli [native and
PEGylated form] or Erwinia chrysanthemi [native
form] are available on the market (3). Moreover,
researchers found that Escherichia coli yielded
preparations that inhibited tumors, compared to
the other bacterial ASNases are very less active
or completely inactive state (4). Subsequently,
the native E. coli ASNase was then used for
developing a drug in the market.
Recently the interest in using ASNases to
treat ALL in adults, specifically young adults has
been increased (5). Among 4000 ALL cases
diagnosed every year in the USA, approximately
two-thirds are children and adolescents, making
  L-Asparaginase a Biotherapeutic for Acute
Lymphoblastic Leukemia – A Molecular Perspective
Manne Anupama Ammulu1, Gorrepati Rosaiah2, Usha Kiranmayi Managmauri2, Praveen
Kumar Vemuri3, K.R.S.Sambasiva Rao1 and P.Sudhakar1*
1Department of Biotechnology, 2Department of Botany and Microbiology,  Acharya Nagarjuna University,
Nagarjunanagrar, Guntur-522510, Andhra Pradesh, India
3Department of Biotechnology, KLUniversity, Guntur-522510, Andhra Pradesh, India
*For Correspondence - sudhakarpodha@gmail.com
Acute Lymphoblastic Leukemia – A Molecular Perspective
Current Trends in Biotechnology and Pharmacy
Vol. 11 (4) 424-443 October 2017, ISSN 0973-8916 (Print), 2230-7303 (Online)
425
ALL the most common cancer among this age
group (6). Around 80% of the children are reported
to have a long-term improvement and an overall
survival rate was 90%, where as in adults the
figures are reduced to 38% and 50% respectively
(7-8). In recent years, there has been reportedly
good progress in leukemia treatment. ASNase is
found widely among many different sources in
nature, found not only in microorganisms, but also
in plants and tissues of various animals like
mammals, birds and fishes. However, microbes
are known to be a better source compared to
animals or plants, due to their ability to grow easily
on simple and inexpensive substrates.
Furthermore, they offer easy optimization of
culture conditions for enzyme over production,
easy genetic modification to increase the yield,
commercially viable upstream and downstream
techniques, good stability and consistency (9).
Many of the l-asparaginases are not suitable
for therapeutic purposes, so many homologous
ASNases have been selected are cloned and
characterized to potentially reduce the side effects
and less toxicity (10). Hence the ideal enzyme
could persist for a longer time in the circulatory
system with reduced antigenic properties. In order
to meet these challenges, many trials have been
made to solve the problem by attaching the
ASNase enzyme with chemicals like polyethylene
glycol (11-12), encapsulation to RBC’s (13),
deimmunization of T-cell epitope removal by
neutral drift (14), trypsin resistance ASNase with
increased stability was achieved by immobilization
technique (15). When ASNase was used
repeatedly due to its short half-life and instability
leads to more serious side effects on the patients.
However, due to chemical modification of the
enzyme reduces the activity of the enzyme. So,
to increase the stability of the enzyme thermo
tolerant ASNase was cloned, purified from E.coli
has been reported (16). Taking into account all
this scenario, the main aim of this review is to
provide a thorough discussion on microbial
ASNase production. More particularly, it focuses
on microbial related productions, recombinant
microorganisms that are likely feasible for a better
cost in the market.
Mechanism of Action
L-Asparaginase produced by different
sources has different half –lives. Different half-lives
of the ASNases preparations lead to the different
durations of depletion of the asparagine. The
action of L-Asparaginase on the leukemic cells
makes them deprive of the asparagine by causing
the hydrolysis of asparagine in to asparatic acid
and ammonia (Fig.1).
Fig 1. Mechanism of action of ASNase on normal and tumor cell
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Normal cells contain the asparagine
synthetase enzyme to fulfill the requirement of
asparagines in their diet and asparagine is a non-
essential amino acid for normal cells. This enzyme
leads to the changes in the characteristics of
asparatic acid by adding an amine group from the
glutamine and hence leads to the production of
asparagine. Asparagine is an essential amino acid
for the tumor cells as they do not have the self-
producing capability of asparagine due to the lack
of asparagine synthetase (17). Protein and RNA
synthesis is inhibited in the absence of
asparagine (18) and as a consequence cell cycle
arrest and apoptosis is induced in leukemia cell
lines (19). To achieve the complete asparagine
depletion in the human circulation, the L-
Asparaginase activity level in serum must be >
100 IU/L (20). It has been reported that tumor cells
can develop the potential to synthesize L-
Asparagine intracellularly, which enables them to
resist the action of the enzyme. The expression
of asparagine synthetase is regulated by
methylation of cytosine residues, which is
responsible for the synthesis of asparagine
synthesis. This offers the  tumor  cells  a  safe
and confirms the  exit from the action of  L-
Asparaginase (21).
Sources of L-asparaginase : Microorganisms
have been proved to be very efficient and
inexpensive sources of L-asparaginase. Large
number of bacteria, fungi, yeast, actinomycetes
and algae are reported as potential source of L-
asparaginase (22).
Bacterial source : From E.coli L-asparginase II
enzyme was isolated by Howard cedar and James
H. Schwatrz (23). The deamidation of L-asparagine
from Escherichia coli, due to the presence of L-
asparaginase II was first reported and identified
by Tsuji. Normally ASNase was produced under
aerobic conditions but a significant higher yield of
the enzyme was found under anaerobic conditions
by using media enriched with high concentration
of different amino acids .Optimum aerobic
conditions have been proved useful for the greater
yield of the enzyme compared to the turbulent
conditions showed high amount of the biomass
resulting in reduced yield of the enzyme.
Ammonium sulfate precipitation and ethyl alcohol
precipitation, purification techniques are proved
to gain 40 folds amount of the enzyme.
Hymavathi et.al. (24) optimized the
conditions for the production of ASNase from a
strain Bacillus circulans MTCC 8574 by solid state
fermentation, by using the agricultural waste as
the suitable nutrient source. Incubation
temperature, moisture content, glucose,  L-
asparagine, inoculum level are the conditions
which affect the yield of the enzyme.
Production of recombinant Erwinia
caratovora L-asparaginase II in E.coli cells by fed-
batch cultures. Using the fed-batch technique with
already determines exponential feeding rates; the
bioreactor culture yielded 30.7 g of dry cell weight
and 0.9 g of soluble rErAII protein per liter of culture
broth (25).
Researchers produced a stable L-
asparaginase enzyme which was tolerant at 450c.
The cloning and expression of ASNase enzyme
from thermo-tolerant strain Escherichia coli
(KH027) was isolated from camel dung and could
grow at 450c. Expression of recombinant
asparaginase was performed by fusion of ASNase
gene to pelB leader sequence and 6His residues
at C-terminal under the inducible T7 promoter in
DH5 cells. The protein that purified through nickel
affinity chromatography showed optimum
conditions at temperature of 430c and pH 6.
Different other sources of bacteria which produce
the enzyme are shown in (Table 1).
Yeast and Fungal sources :  The production of
Asparaginase from various strains of fungi has
been reported using a different range of media.
The production of ASNase by filamentous fungi
such as Aspergillus tamarii and Aspergillus terreus
has been reported with highest L-asparaginase
production level in 2% proline medium from A.
terreus (26). The production of asparaginases from
fungi by various methods has been reported and
L-asparaginase producing fungus, Aspergillus
terreus was isolated and various parameters for
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ASNase production through solid state
fermentation were optimized (27). L-proline is the
best nitrogen source for the production of ASNase
from A. terreus for maximum asparaginase activity
using latin square design (28). The Penicillium
sp. from the soil producing ASNase with anti-
oxidant properties has been found (29).
   The ASNase enzyme was purified to
homogeneity from Penicillium sp. that was grown
on submerged fermentation. This purified enzyme
showed 13.97 IU/mg specific activity and 36.204%
yield. The enzyme showed maximum activity at
7 pH and 37°C. This shows that the enzyme is
independent on pH particularly from this organism
(30).
      Abha Mishra et.al., (31) was the one who
reported higher yield of the enzyme from a different
isolate of Aspergillus niger, agro waste from the
leguminous crops as a source. She followed the
process of solid state fermentation (SSF). Bran
of Glycine max was used as a main source of
nutrients gave highest yield of enzyme, which was
further followed by the Phaseolus mungo, and
Cajanus cajan.
Actinomycetes sources : The first L-asparaginase
from actinomycetes was reported in Nocardia spp.
(32). Production of intracellular and extracellular
asparaginases from Streptomyces spp. was also
studied (33, 34). Saleem  et.al. (35) is the first to
report on the production and partial purification of
L-asparaginase from marine actinomycetes
isolated via solid state fermentation (SSF). In the
final purification step, the enzyme showed a
specific activity of 662.61 IU/mg, which is
approximately 2-fold purity. Optimum pH was found
to be 7.5, which is close to blood pH, compared
to L-asparaginases from other bacterial sources
such as Serratia marcescens, Mycobacterium
spp. and Pseudomonas spp. showed optimum
pH in the range of 8.0 to 8.5. At 50 °C, the enzyme
showed its optimum activity.
    A potential extracellular ASNase was
characterized from the Streptomyces griseus
NIOT-VKMA29. Box-Behnken based optimization
was used to determine the culture medium
components to enhance the L-asparaginase
production. In this report the authors have
performed molecular characterization ad design
of the ASNase gene. Further ASNase
biosynthesis gene (ansA) from Streptomyces
griseus NIOT-VKMA29 was heterologously
expressed in Escherichia coli M15 and the
enzyme production was increased threefold (123
IU mL”1) over the native strain (36). Few more
actinomycetes sources with the enzyme activity
are given in (Table 2).
Plant sources : A few variety of plant species are
described with significant amount of asparaginase.
Green chillies (Capsicum annum L.) and tamarind
(Tamarindus indica) contain certain amount of
ASNase and the enzyme was purified using
ammonium sulphate precipitation, sephadex gel
filtration and affinity chromatography (37). Enzyme
that was isolated from the green chillies was
purified up to 400-folds by various methods and it
was observed that enzyme exist in two forms and
only one of them showed the anti-tumor activity.
Enzyme had a pH of 8.5 and a temperature
optimum of 37°C. Gene encoding for ASNase
enzyme was isolated from plant, Lupinus
angustifolius (38). The low temperature inducible
cDNA sequence that encodes ASNase was
isolated from soybean leaves and cloned
expressed in E.coli with almost has 3 times
increased activity (39). Withania somnifera is the
potential source of enzyme ASNase on the basis
of high specificity of enzyme. The ASNase
producing micro-organisms from Ocimum
sanctum L were screened and characterized.
ASNase from Withania somnifera was cloned and
over expressed in E. coli with anti-cancer
properties (40).
Algal sources : ASNase from a marine
Chlamydomonas spp. has been purified in 1982.
This L-asparaginase has shown limited antitumor
activity in anti-lymphoma assay in vivo. Properties
of this L-asparaginase varied with those of
asparaginase from prokaryotic and eukaryotic
microorganisms (41).
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Disadvantages of L-asparginase production
from bacteria : Bacterial sources are better
described for commercial production of L-
asparaginase. Properties of ASNase vary from
microorganism to microorganism and contrasted
with those of prokaryotic and eukaryotic sources
(56). ASNase from bacterial sources causes
hypersensitivity in the long-term use, leading to
allergic reactions and anaphylaxis. It has been
observed that eukaryotic microorganisms like
yeast and filamentous fungi genera have a
potential for ASNase production with less adverse
effects than prokaryotic microorganisms. The
search for other ASNase sources, like eukaryotic
microorganisms, can lead to an enzyme with less
adverse effects (57).
 Mode of optimization and production process
: Researchers performed submerged fermentation
for the production of the enzyme ASNase. They
have taken the soil sample of Bacillus spp., culture
conditions were optimized for producing the higher
yield of the enzyme (58). The carbon sources like
maltose and glucose were used for the production
of the enzyme. The most adopted method of
production of ASNase enzyme is from submerged
fermentation, which has been performed throughout
the world. Some limitations of process were
observed in later research and to overcome those
disadvantages method of solid state fermentation
has been adopted. It has several advantages
compared to submerged fermentation like low
capital cost, higher yield of the product, low energy
consumption, usage of less water, simple
fermentation media (59-60).
           In SSF agricultural waste can be used as
source of nutrients which is cost effective and
environment friendly (61). SSF holds high potential
for the production of secondary metabolites and
has been increasingly applied in recent years (62).
Abha  et.al., reported higher yield of the enzyme
from a different isolate of Aspergillus niger, agro
waste from the leguminous crops as a source.
An attempt was made to study the optimized
production of L-Asparaginase by Fusarium equiseti
using soya bean meal under solid state
fermentation (SSF) by Hosamani et. al., (63). Solid
state fermentation has emerged as a potential
technology for the production of microbial products
utilizing the cheaply available raw materials. Soya
bean meal proved to be one of the best substrate
Table 2. L-asparaginase production by various fungal speices.
S.No Fungal sp Substrate/ Operating Fermen- Activity Reference
Media  conditions tation  reported
1. Aspergillus Bran of glycine 30°C, pH – SSF 40.9 U/g (52)
niger max,Moisture- 70% 6.5, 96 h
2. Aspergillus L-Asparagine – 30°C, pH – 6.5, SMF 19.5 IU/mL (53)
sp 2%,Glucose – 1%, 160rpm,
Ammonium inoculum –
sulphate – 1%  2%,48 h
3. Aspergillus Sesame cake 32°C, Aeration PBR-SSF 344.21 IU/g (54)
niger – 0.4vvm, Bed
height 22cm
4. Aspergillus Carob pod 35°C, pH – SSF 6.05 IU/g (55)
terreus with 65%moisture 35°C, pH – 4.5,
content,30 mm 72 h 4.5, 72 h
bed depth,
particle size 2 mm
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for L-Asparaginase production. In the present study
production of L-Asparaginase started at 24 hours
and reached maximum at 48 hours and then
decreased significantly with increase in the
incubation time.
Optimization of production level of L-
Asparaginase from Erwinia carotovora was done
by Vaibhav et.al., (64). A Central composite
Rotatable Design (CCRD) of Response Surface
Methodology (RSM) was used to determine the
combined effect of the three variables viz. Yeast
Extract, Maltose and L-asparagine which were
identified earlier using ‘one-factor-at-a time’
approach by them. The significant variable was
Yeast Extract among three variables.
Extracellular L-asparaginase was produced
using a fungi isolated from soil. The effect of
various physical and chemical parameters was
optimized for extracellular L-asparaginase
production under submerged fermentation. The
maximum L-asparaginase activity of 19.5 U/mL
was obtained using MCD medium containing 2%
(w/v) L-asparagine as substrate, 1% glucose as
carbon source, 1% ammonium sulphate as an
additional nitrogen source. The optimum process
parameters for maximum L-asparaginase
production were: Incubation time 96 h, incubation
temperature at 30ºC, initial pH 6.5 and inoculum
level 20% (v/v) with 48 h old inoculum (65). The
filamentous fungi Bipolaris spp. isolated from
brown rice in Thailand was identified to produce
extracellular L-asparaginase. The maximum L-
asparaginase activity of 6.3 U/mL was obtained
using MCD media containing 1% L-asparagine
and 0.4% glucose at 30ºC in 72 h of incubation.
L-asparaginase from Bipolaris sp. was proved to
be non-cytotoxic when tested against Vero cell
lines and has potential application in food industry.
L-Asparaginase production by Aspergillus
sp. under solid state fermentation was studied
using different agro-industrial wastes such as rice
bran, green gram bran, wheat rawa, wheat bran,
bombay rawa, black gram bran, barley, saw dust,
jowar flour, rice flour, castor oil cake, groundnut
oil cake, coconut oil cake and sesame oil cake
as substrate. Of all the substrates studied that
supported growth and enzyme formation by the
fungi,  groundnut  oil  cake  showed the  highest
L-asparaginase production. The maximum
production of L-asparaginase (60 U/gds) was
achieved by using groundnut oil cake. The
optimum process parameters for maximum L-
asparaginase production were: Incubation period
of 5 days, initial moisture content of solid substrate
90%, 1:10 (v/w) ratio of salt solution to weight of
groundnut oil cake, inoculum level 20% (v/w),
incubation temperature at 30°C and initial pH 6.5.
Enzyme in recombinant form : Due to very high
cost of medicinal drug to be used against cancer
and side effects of L-asparaginase isolated from
E. coli, the enzyme is cloned in other vectors to
improve the characteristics of the enzyme and
reduce the side effects of the enzyme. As the
enzyme is mainly used as anti-cancer drug,
therefore, the recombinant techniques must be a
part of the process adopted for the production of
Asparaginase, which can help in reducing the
allergic reaction produced by the enzyme and also
the cost of the final product as well as the
treatment. Considering the importance of
implementation of recombinant techniques,
Priscila Lamb Researchers have adopted a work
plan:
a) Cloning of E. Carotovora subsp. Atroseptica
L-Asparaginase II era gene,
b) Protein expression in E. coli cells,
c) Purification of the recombinant enzyme and
d) Measurement of Asparaginase activity and
kinectic characterization of this enzyme
Another attempt for generating the
recombinant form of the enzyme was made by
the Harry et.al. They constructed the whole
genomic library of Erwinia chrysanthemi in
bacteriophage A1059 and purified, isolated anti-
Asparaginase IgG were used to detect the
recombinants expressing the enzyme. The gene
was subcloned in pUC9 and sub-cloning was done
to get the actual position of the gene.
Recombinants were not observed to repress
glycerol as their sole source rather they repress
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glucose. Recombinants cells of Erwinia carotovora
resulted in increased yield of the enzyme (66). To
increase the production level of the enzyme,
overproducing L-Asparaginase strains through
protoplast fusion technique between two highly
L-Asparaginase- producer local isolates, i.e.,
Bacillus subtilis and B. cereus was developed by
Wafaa et.al., (67).  B. subtilis was found to be
sensitive to rifampcin (Rifs) and could utilize L-
Asparagine as a sole source of nitrogen while
Bacillus cereus was resistant to (Rifr), does not
grow on minimal medium and cannot utilize L-
asparagine.
Treating the cells with 1 mg/ml lysozyme
for three hours in SMM buffer caused the protoplast
fusion. Protoplast regeneration was successfully
obtained on sodium-succinate medium where
protoplast regeneration rates were 39.8 and 25.6%
for Bacillus subtilis and B. cereus, respectively.
Protoplast fusion was performed between the two
parental protoplasts in the presence of 40% PEG
6000. Among forty five fusants, 18 showed
significant higher L-Asparaginase activity, they
produced approximately 2.5 fold more L-
Asparaginase.
L-Asparaginase production by Aspergillus
sp. under solid state fermentation was studied
using different agro-industrial wastes such as rice
bran, green gram bran, wheat rawa, wheat bran,
bombay rawa, black gram bran, barley, saw dust,
jowar flour, rice flour, castor oil cake, groundnut
oil cake, coconut oil cake and sesame oil cake
as substrate. Of all the substrates studied that
supported growth and enzyme formation by the
fungi, groundnut oil cake showed the highest L-
asparaginase production. The maximum
production of L-asparaginase (60 U/gds) was
achieved by using groundnut oil cake. The
optimum process parameters for maximum L-
asparaginase production were: Incubation period
of 5 days, initial moisture content of solid substrate
90%, 1:10 (v/w) ratio of salt solution to weight of
groundnut oil cake, inoculum level 20% (v/w),
incubation temperature at 30°C and initial pH 6.5
(68).
Different patterns of expressions of
recombinant L-Asparaginase in different E. coli
hosts were studied by Gustavo et.al. Mutant
strains of E. coli were constructed by genetic
manipulations with the help of recombinant tools.
After amplification of the L-Asparaginase gene
from Erwinia carotovora, the gene was cloned into
the expression vector pET30a (+) and used to
transform different E. coli strain by electroporation
method. A control was kept to verify the results.
The E. coli strains used were: BL21 (DE3) NH,
BL21 (DE3) Star, C41 (DE3), C43 (DE3), Rosetta
(DE3), and BL21 (DE3). The cultures were
maintained on TB medium at 37°C. As a control,
the E. coli strain was transformed with the plasmid
lacking the L-Asparaginase gene. For expression
analysis, 1 mL of the cultures were submitted to
electrophoresis on SDS-PAGE. All E. coli strains
tested showed the higher expression of the L-
Asparaginase at 37°C. At the moment, the
cultures are being tested at 30°C in order to
observe if the temperature will influence in the
expression of the protein. The results were
promising and can be used for the scale up
process to increase the production level of the
enzyme (69).
Purification of Enzyme : Juan et.al., (70)
discovered L-Asparaginase in a significant active
form when lysine is over produced in cultures of
Corynebacterium glutamicum.  Purification
measures adopted by them include:
· Protamine sulphate precipitation,
· DEAE-Sephacel anion exchange,
· Ammonium sulphate precipitation and
· Sephacryl S-200 gel filtration
98-fold purification was adopted by these
methods and the purified enzyme was eluted from
gel, when subjected to PAGE, in an active form.
The enzyme, sometimes, produced intracellularly.
Purification of L-Asparaginase from
Acinetobacter calcoaceticus was done by
precipitation with streptomycin, chromatography
on DEAE-cellulose and CM-cellulose, gel filtration
on agarose and chromatography on
phosphocellulose. The enzyme catalyzed the
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deamination of L-glutamine to about the same
extent as L-asparagine and showed a weak tumor
inhibitory power (71).
Bacterial L-asparaginases catalyze the
conversion of L-asparagine to L-aspartate and
ammonia. Kotzia et.al., (72) reported the cloning
and expression of L-asparaginase from Erwinia
chrysanthemi 3937 (ErLASNase) in Escherichia
coli BL21(DE3) and purification of the enzyme was
done by a single-step procedure involving cation
exchange chromatography on an S-Sepharose FF
column which showed comparatively high activity.
L-Asparaginase (Isozyme II) from E. coli was
cloned and expressed extracellularly. The
resulting recombinant protein was purified by a
single step using Ni-NTA affinity chromatography
which gave an overall yield of 95 mg/L of purified
protein, with a recovery of 86%. This is
approximately 8-fold higher to the previously
reported data in literature (73).  Gladilina et.al.,
(74) reported the cloning and expression of
recombinant protein from Helicobacter pylori J99
in E. coli (BL21) which was first purified up to 1.8
fold, then sonicated for the preparation of cell free
extract and the enzyme was purified from the
soluble fraction of cell free extract by
chromatography on SP-Sepharose which gave
more than 60% yield.
Statistically based experimental design was
done to assess the physical process parameter
was applied to maximize the production of
glutaminase-free L-asparaginase from
Pectobacterium carotovorum MTCC 1428 which
after purification via a three step process enhanced
the production and productivity of L-asparaginase
by 26.39% (specific activity) and 10.19%,
respectively (75).
Purification of the L-asparaginase enzyme
to homogeneity from Pseudomonas aeruginosa
50071 cells that were grown on solid-state
fermentation was done by applying different
purification steps including ammonium sulfate
fractionation followed by separation on Sephadex
G-100 gel filtration and CM-Sephadex C50crude
culture filtrate. The enzyme was purified 106-fold
and showed a final specific activity of 1900 IU/mg
with a 43% yield by Khushoo et.al., (74).
The recombinant L-asparaginase enzyme of
Pyrococcus koshii was expressed in E.coli (BL21)
and purified by anion exchange chromatography
and gel filtration followed by hydrophobic
interaction chromatography and ultrafiltration. L-
asparaginase of Streptomyces tendae isolated
from laterite soil samples of Guntur region and
the crude enzyme was purified to homogeneity
by ammonium sulfate precipitation, Sephadex G-
100 and CM-Sephadex G-50 gel filtration (77).
Immobilization of the enzyme : Some of the
major limitations in the use of the enzyme are its
severe immunological reactions and a very short
serum half-life. Modifications like formulation and
immobilization of the enzyme onto a suitable
matrix can greately reduce the immunogenicity
of the enzyme; increase its half-life and its
therapeutic potential.
 The immobilization of E.coli L-
asparaginase into a hydrogel matrix made of poly
(ethylene glycol) PEG and BSA showed a 200
fold increase in its Km value and a wider pH range
for the optimal activity of the enzyme with 90% of
activity at physiological pH of 7.3 as compared to
43% activity for the native form. Also the half-life
of the immobilized enzyme enhanced to 50 days
with 90% activity at 37 ºC as compared with the
half-life of 2 days for the native enzyme. In an
another experiment, they  coupled  E.coli
asparaginase in a biocompatible hydrogel made
of rat serum albumin and PEG and assessed for
its effectiveness to deplete the serum L-asparagine
in vivo. It was found that 85-90% of serum
asparagines got depleted in 2 days with 5 units/
rat and also 80% activity of the enzyme was still
retained even after 10 days (78). Vina et.al., (79)
and other reported the immobilization of L-
asparaginase from Erwinia carotovora on a
biologically active fructose polymer levan of
different molecular mass (75 and 2000 kDa)
obtained from Zymomonas mobilis. They
employed the method of periodate oxidation of
the polysaccharide followed by reductive alkylation
which retained.
Acute Lymphoblastic Leukemia – A Molecular Perspective
Current Trends in Biotechnology and Pharmacy
Vol. 11 (4) 424-443 October 2017, ISSN 0973-8916 (Print), 2230-7303 (Online)
433
Immunological side effects and enzyme
instability : ASNase administration can promote
a number of harmful side effects including
immunological responses, ranging from allergic
reactions to fatal anaphylactic shock, pancreatitis,
coagulation, hyperglycemia, protein synthesis
inhibition and hepatotoxicity (80). As far as the
immunological side effects are present, the decay
of ASNase antitumoral activity is directly
associated with the production of L-asparginase
antibodies by the patient, which leads to the drug
clearance from the bloodstream and reduces the
treatment efficacy. In this respect, early studies
have shown high circulating levels of ASNase by
ELISA with low enzyme activity, which was initially
attributed to L-asparginase denaturation (81).
However, more recent studies suggest that
ASNase clearance may be a result of protease
cleavage (82). Immunogenic effects and Protein
stability are apparently closely related. The
proteolytic cleavage of ASNase may be
responsible for additional epitopes exposure,
which is involved in the patients’ immune response
. Hypersensitivity occurs more frequently when
the treatment is interrupted, with children
presenting less hypersensitivity and antibody
production when compared to adolescents and
adults (83-84).
Formulation and Modification of the Enzyme
: L-Asparaginase has certain side effects and very
less half life. Its dosage activates the immune
response in the body. It is the need of time to
reduce the immunogenicity of the drug with some
modification in the structure of the drug. Various
formulations and modifications has been tried to
improve the influence of the drug. The enzyme
from the E. coli was modified by Kodera et.al.,
(85).  They manipulated the enzyme by coupling
it with two types of comb shaped copolymer of
polyethylene glycol derivative and maleic
anhydride with multivalent reaction sites. This
coupling improves the half life of the modified drug
and stabilizes it. The serum retained in the body
for a longer period.
Another experiment was performed by
Yoshihiro  et.al. They modified the enzyme from
E. coli A-1-3 with activated polyethylene glycols
with molecular weights of 750, 1900 and 5000.
The modification of enzyme did not show any
significant results and the retained enzymic
activity was just 7% mPEG2 (2,4
bis(Omethoxypolyethyleneglycol)- 6-chloro-S-
triazine) is also used to modify the enzyme by
Zhang et al. (86), it is performed in the presence
of L-asparagine and the molar ratio maintained
was mPEG2/-NH2 was 10. The modified enzyme
retained 33% of initial enzymatic activity with
complete abolishment of immunogenicity and in
vitro half-life get increased from 4.6 h to 33 h has
been obtained (86).
Cross linkage was the technique adopted
by Handschumacher et.al., to modify the enzyme
to reduce its side effects. They used the dimethyl
suberimidate to cross link the tetrameric form of
enzyme from E. coli. The cross linkage cause
the reduction in the activity of enzyme and only
17% of the total activity was retained after
modification. Approximately 60% of the enzyme
is converted to dimers and higher oligomers (87).
The modified L-Asparaginase from E. coli
retained the activity of 8% after the modification
with monomethoxypolyethylene glycol, reported
by Kamisaki et.al., (88). Cyanuric acid chloride
was used as a coupler in the reaction. The modified
enzyme did not react with the anti- L-Asparaginase
antibody in precipitin reaction. It has the same
Km value for L-Asparagine and the same optimal
pH as the native enzyme. The immunogenicity of
the modified enzyme was substantially reduced
because mouse antiserum to it showed no
significant increase in hemagglutinin titer of L-
Asparaginase-coated sheep red blood cells (88).
Fermentation kinetics of L-asparaginase
production : Although the production of bacterial
ASNases from wide range of bacterial sources
has been studied extensively by various
researchers during the last few decades, the
kinetics of production of this enzyme has not been
explored in detail. Liu et al in reported the kinetics
of ASNase production by E. aroideae and
Arrivukkarasan et.al., reported the kinetics of L-
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asparaginase production by P. carotovorum. The
fermentation kinetics and continuous production
of ASNase was first studied in the bacterial source
E. aroideae. Cell growth and ASNase production
were investigated in both batch, fed-batch and
continuous fermentation using yeast extract as a
growth limiting substrate. The relationship between
specific growth rate and substrate concentration
was found to fit the Monod model. The optimum
temperature for enzyme production was 24°C,
though cell growth was higher at 28°C. The
enzyme yield reached its maximum of 4 IU/mL
during the negative acceleration growth phase
which occurs just prior to stationary growth.
Compared to batch fermentation, the continuous
fermentation process gave a lower ASNase yield.
The optimum temperature for L-asparaginase
production in batch process was 24°C, which was
the same as in continuous process. Increasing
the temperature from 24°C to 28°C resulted in a
20% loss of L-asparaginase yield .
            Kinetics of L-asparaginase production by
P. carotovorum MTCC 1428 in submerged
fermentation (SMF) was studied using yeast
extract–tryptone–galactose media, keeping
constant fermentation conditions at temperature
30°C, initial pH 7.0 and agitation speed of 120
rpm. The production medium was inoculated with
5% v/v of seed culture in its mid-exponential phase
at 24 h. The maximum production of periplasmic
and extracellular ASNase was 3.25 and 0.83 U/
mL, respectively, at 30 h of fermentation.
Unstructured kinetic models such as logistic
model for cell growth, incorporated Luedeking–
Piret model for L-asparaginase production and
logistic incorporated modified Luedeking–Piret
model for substrate utilization kinetics were
satisfactorily described the fermentation profile of
P. carotovorum. Kinetics of L-asparaginase
production by P. carotovorum in submerged
fermentation (SMF) was studied using YET (yeast
extract–tryptone) media, keeping constant
fermentation conditions at temperature 30°C, initial
pH 7.0 and agitation speed of 120 rpm. The
maximum intracellular and extracellular L-
asparaginase activity of 2.28 U/mL and 0.58 U/
mL, respectively, were obtained at the late
logarithmic phase. The unstructured models
predicted the cell growth and product formation
profile accurately with high coefficient of
determination. No report has been found on
kinetics of fungal ASNase production. The
information on kinetics of ASNase production was
unexplored over a long period of time in spite of
its increased commercial need as high value
therapeutic protein. The cost of this therapeutic
enzyme is high due to the lack of efficient
production of this enzyme at large scale. Hence
it is important to focus on the kinetic modeling of
ASNase production with less adverse effect by
fungal sources in submerged fermentation to
develop economically viable and efficient
bioprocess.
Statistical optimization of L-asparginase
production : Screening and evaluation of
environmental and nutritional requirements of
microorganism is an important step for bioprocess
development. Optimization studies involving one
factor at a time approach is tedious and tends to
overlook the effect of interacting factors but may
lead to misinterpretations of the results. In contrast
statistically designed experiments tackle the
problem effectively, which involves the specific
pattern of experiments, which minimizes the error
in determining the effect of parameters, and the
results are acquired in an economic manner (89).
The statistical design of experiments is an efficient
procedure for designing experiments so that the
data acquired can be analyzed to yield valid and
informative conclusions. The planning of
experiments begins with determining the objectives
and choosing the process variables for the study.
An experimental design is the complete
layout of a detailed experimental plan in process
of doing the experiment. A screening experiment
is performed in order to determine the
experimental variables that have significant
influence on the response variables. Plackett–
Burman (PB) design is an effective screening
design when main parameters are to be
considered. This is a very economical design with
the run number being a multiple of four and
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comprises of two-level screening designs. PB
experimental design does not consider the
interaction among the variables on response
variable and it is based on the first-order model.
This design is very useful in finding the importance
of the factors affecting the product yield in
bioprocesses (90).
 Response surface methodology (RSM) is
a statistical technique based on the fundamental
principles of statistics, randomization, replication
and duplication, which simplifies the optimization
process by studying the mutual interactions
among the variables over a range of values in a
statistically valid manner. It is an efficient statistical
technique for optimization of multiple variables in
order to predict the best performance condition
with a minimum number of experiments. These
designs are used to find improved or optimal
process settings, troubleshoot process problems
and weak points and make a product or process
more robust against external and non-controllable
influence. Central Composite Design (CCD) is one
of the RSM usually utilized to obtain data that fits
a full second-order polynomial model. Variables
are coded as ±1 for factorial points, 0 for the center
points and ± 2 for axial points. The effect of process
variables on response is fit into the second-order
polynomial model and it is solved for optimum
level of process variables to give maximum
response. Statistically based experimental design
was applied for optimization of a solid-state
fermentation for the production of L-asparaginase
by Pseudomonas aeruginosa 50071.
PB factorial experimental design was used
for evaluation of various culture conditions for their
significance on L-asparaginase production.
Casein hydrolysate, corn steep liquor and pH were
identified as the most significant factors for
improving L-asparaginase production process.
Box–Behnken design, a type of RSM was used
to find the optimum value significant factors for
maximum L-asparaginase activity. The maximum
L-asparaginase activity of 142.8 IU was obtained
at the predicted optimum conditions of pH 7.9,
casein hydrolysate 3.11%, and corn steep liquor
3.68%. L-Asparaginase production by
Zymomonas mobilis by sugarcane molasses
fermentation was optimized using factorial
experimental design. A model obtained by the
response surface methodology was good fit of the
experimental data. Maximal enzyme activity of
16.55 IU/L was predicted under the optimum
conditions of molasses 100.0 g/L of total reducing
sugars, yeast extract 2.0 g/L and fermentation
time 21 h. The effect of fermentation process
parameters for the production of L-asparaginase
by isolated Staphylococcus spp. was evaluated
using Taguchi methodology, a type of fractional
factorial experimental design. The carbon source,
nitrogen source, incubation temperature, medium
pH, aeration, agitation and inoculum level were
evaluated and it was reported that incubation
temperature, inoculum level and medium pH were
the major influential parameters at their individual
level, and contributed to more than 60% of total
L-asparaginase production .
 The interaction effect of incubation
temperature, moisture content, inoculum level,
glucose and L-asparagine on L-asparaginase
production by Bacillus circulans MTCC 8574 under
solid state fermentation was optimized using
fractional factorial central composite design. L-
asparagine and incubation temperature were found
to have significant linear and quadratic effect on
L-asparaginase production. L-Asparaginase
production was improved from 780 to 2,322 U/
gds. The effect of various carbon and nitrogen
sources on production of L-asparaginase by
isolated B. circulans MTCC 8574 under
submerged fermentation was studied using PB
experimental design. Ammonium chloride and
glucose were found to be the most significant
carbon and nitrogen source respectively for L-
asparaginase production. Statistically planned
experimental designs were applied to maximize
the production of glutaminase free L-asparaginase
from P. carotovorum MTCC 1428 under submerged
fermentation. The fermentation media components
such as glucose, L-asparagine, KH2PO4 and
MgSO4.7H2O were identified to have significant
influence on the production of L-asparaginase
using the PB experimental design. The optimum
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levels of glucose, L-asparagine, KH2PO4 and
MgSO4.7H2O were found to be 2.07, 5.20, 1.77
and 0.37 g/L, respectively, using the central
composite experimental design. The maximum
specific activity of L-asparaginase in the optimized
medium was 27.88 U/mg of protein, resulting in
an overall 8.3-fold increase in production. Effect
of various medium components on the production
of L-asparaginase under submerged fermentation
by P. carotovorum was studied for optimal nutrient
requirements. Maximum intracellular and
extracellular L-asparaginase activity was obtained
in the medium containing tryptone, yeast extract,
monosodium glutamate, K2HPO4 and L-
asparagine. These medium components were
optimized by central composite experimental
design.
Maximum intracellular and extracellular L-
asparaginase activity of 2.28 U/mL and 0.58 U/
mL were obtained respectively in optimized
media. Yeast extract, galactose, monosodium
glutamate, MgSO4.7H2O and CaCl2.2H2O were
identified to be the most significant components
on production of L-asparaginase by P. carotovorum
MTCC 1428 under submerged fermentation. The
significant components were further optimized
using CCD. Maximum periplasmic and
extracellular L-asparaginase product yields of 3.25
U/mL and 0.83 U/mL, respectively, were obtained
using the optimized medium components of yeast
extract 20.8 g/L, galactose 9.16 g/L,
monosodium glutamate 9.89 g/L, MgSO4.7H2O
0.304 g/L and CaCl2.2H2O 0.042 g/L (91). Although
there are many reports found on statistical
optimization of bacterial L-asparaginase
production, there is no report has been found on
statistical optimization of fungal L-asparaginase
production. Hence it is important to focus on
statistical optimization of media components and
process conditions for the production of fungal L-
asparaginase to develop cost effective and efficient
bioprocess.
 Applications of L-Asparaginase
The enzyme ASNase has the
chemotherapeutic property against the tumor
cells. It is an effective therapeutic enzyme against
the treatment of cancers like acute lymphoblastic
leukemia. This enzyme helps in catalyzing the
hydrolysis of L-asparagine into L-aspartic acid and
ammonia. The principle behind the use of ASNase
as an anti-tumor agent is that it takes the fact
that all leukemic cells cannot synthesize the non-
essential amino acid ASN on their own, which is
very essential for the growth of the tumor cells,
whereas the normal cells can synthesize their
own asparagine; thus tumor cells require high
amount of asparagine.
L-Asparaginase has a significant role also
in food industry. L-Asparaginase from fungal
sources is used as food processing aid in food
and allied industries to reduce the formation of
acrylamide. JECFA (Joint Expert Committee on
Food Additives) has recommended the use of
L-asparaginase to reduce acrylamide formation
for its carcinogenicity and neurotoxicity during
processing of high-starch food products (JECFA
2001). Acrylamide is formed as a reaction product
between asparagine and reducing sugars
contained in starchy food products such as potato
chips, frech fries, gingerbreads, roasted coffee and
wheat dough based products such as biscuits
and crisp breads when heated above 120°C during
baking or frying. The heat induced reaction
between a reducing sugar and asparagine, which
is one of the reaction pathways of the Maillard
reaction, forms acrylamide. The Maillard reaction
is the process that gives the brown colour and
tasty flavour of baked, fried and toasted foods.
Incubation of unbaked or un-fried starchy foods
with  L-asparaginase solution at 37ºC reduces
acrylamide level in fried foods up to 90% by
converting asparagine into aspartic acid and
ammonia, without altering the appearance, taste
and quality of the final product (92).
In biosensors: L-asparaginase is applicable
in asparagine levels sensing in mammalian and
hybridoma cells or the food industry . L-
asparaginase used as antioxidant: capable to
reduce free oxygen radicals.
Conclusion
The discovery of the fact that ASNase is
responsible for the action of anti-tumor activity
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against the acute lymphoblastic leukemia has set
a good mark in the field of medicine. After this
discovery clear information about the enzyme and
its mode of action has been dug out. It has been
already proved that L-Asparaginase from E.coli
and Erwinia carotovora has anti-neoplastic activity
against leukemia and is being used as anti-cancer
drugs. But, thorough research it is observed that
the action of enzyme is leading to some side
effects. Moreover, the yield of enzyme from the
present discovered sources was not sufficient to
fulfill the demand of the drug. Solid state
fermentation has more advantages compared to
submerged fermentation to it is adopted at larger
scale all over the world. So, there was a need to
discover new sources and production techniques
to enhance the yield and reduce the side effects
of the enzyme. Enzyme isolated from various
sources has different optimized conditions for
production and activity. The structure of enzyme
that was predicted from E. coli has four identical
units. Recombinant and formulation of enzyme is
already in progress, yet there is still a long way
to go to increase the yield of the enzyme.
Moreover,  L-Asparaginase has also have its
applications in food industry, as an essential
ingredient in reducing the toxicity of baked food
by minimizing the amount of acrylamide in food
items. So, there is a need to fulfill the thirst of the
enzyme because there is a lot of demand for the
enzyme in medicine and food industry.
        Rational protein engineering based on
protein structure is another upcoming strategy to
produce ASNases with improved
pharmacodynamics, pharmacokinetics and
toxicological profiles. Further, approaches involving
site directed mutagenesis of residues in the
enzymes active site were able to produce
recombinant enzyme with good ASNase activity,
and negligible GLNase activity. Additional
procedures involving the introduction of structural
disulfides and cutting of proteases cleavage sites
may allow the production of more robust enzymes.
There is little information on Saccharomyces
cerevisiae ASNase and, giving the easy possibility
of cultivation and possibility of genetic manipulation
of this yeast, they believe that such an enzyme
is possible to be better investigated as an
alternative to the existing bacterial ASNases. In
particular, special attention has to be paid to its
better structural and kinetic characterization as
well as to the rational engineering of the yeast
enzymes by means of site-directed and random
mutations. Another interesting technological
approach that may contribute to improve the yield
of ASNase production by recombinant
microorganisms is the metabolic flux analysis
(MFA), it is a powerful tool to postulate the
metabolic state constrained by exchange of
nutrient fluxes between cells and environment.
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